Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07576322
NA

Short-Term Safety and Performance of a Wound Dressing Evaluation

Sponsor: Sebastian Probst

View on ClinicalTrials.gov

Summary

You can paste the following into the \*\*Brief Summary\*\* field: POLTX\_CIP\_template\_e\_klinv-mep\\\_… The goal of this study is to learn about the safety, wound healing, and ease of use of POLTX\_Fiber, an absorbent wound dressing that forms a gel when it takes up wound fluid. The study will include approximately 60 adults receiving outpatient care in Switzerland. Participants will have wounds that have been present for at least four weeks and produce moderate to large amounts of fluid. These may include venous leg ulcers, diabetic foot ulcers, pressure ulcers, or ulcers with more than one cause. The main questions are: * What health problems or dressing-related problems occur during the study? * How much does wound size change after 30 days of treatment? * Can POLTX\_Fiber be removed completely in one piece? * How easy is the dressing to apply and remove, and how comfortable is it for patients? Participants will receive either POLTX\_Fiber or Suprasorb Liquacel Pro, another absorbent wound dressing. Dressing assignment will follow a predefined schedule rather than chance. Participants and their care teams will know which dressing is used. Results for each dressing group will be described separately. Participants will: * Receive their assigned dressing for up to 30 days, with dressing changes as needed. * Continue usual care for the underlying cause of their wound. * Attend wound assessments at the start of treatment, weekly during treatment, and at weeks 8 and 12. * Have their wound measured and photographed and checked for signs of infection. * Rate pain during dressing changes and report how comfortable the dressing feels. After the study treatment ends, participants will receive wound dressings prescribed by their care team. Each participant will take part for 12 weeks.

Official title: A Post-market Clinical Follow-up Study to Describe the Short-term Safety, Performance and Usability of poltx_fiber in Chronic Wounds

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-12-01

Completion Date

2027-11-30

Last Updated

2026-11-16

Healthy Volunteers

No

Interventions

COMBINATION_PRODUCT

Politix Fiber arm

POLTX\_Fiber is a CE-marked absorbent gelling fibre wound dressing. It absorbs wound fluid and forms a gel to maintain a moist wound environment. The dressing will be applied directly to the study wound according to the manufacturer's instructions for use for up to 30 days or until wound closure, whichever occurs first. Dressing changes will depend on wound fluid levels and clinical needs. Participants will continue standard care for the underlying wound condition.

Locations (3)

Hirslanden Clinique des Grangettes

Chêne-Bougeries, Canton of Geneva, Switzerland

Lausanne University Hospital

Lausanne, Canton of Vaud, Switzerland

Instituions Hospital Du Nord Vaudois

Yverdon-les-Bains, Canton of Vaud, Switzerland